- Home
- ACAD vs SID Comparison
ACAD vs SID Comparison
Compare ACAD & SID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACAD
- SID
- Stock Information
- Founded
- ACAD 1993
- SID 1941
- Country
- ACAD United States
- SID Brazil
- Employees
- ACAD N/A
- SID N/A
- Industry
- ACAD Biotechnology: Pharmaceutical Preparations
- SID Steel/Iron Ore
- Sector
- ACAD Health Care
- SID Industrials
- Exchange
- ACAD Nasdaq
- SID Nasdaq
- Market Cap
- ACAD 2.6B
- SID 2.7B
- IPO Year
- ACAD 2004
- SID 1997
- Fundamental
- Price
- ACAD $16.30
- SID $1.91
- Analyst Decision
- ACAD Buy
- SID Sell
- Analyst Count
- ACAD 19
- SID 2
- Target Price
- ACAD $26.44
- SID $2.95
- AVG Volume (30 Days)
- ACAD 1.4M
- SID 2.3M
- Earning Date
- ACAD 11-06-2024
- SID 11-12-2024
- Dividend Yield
- ACAD N/A
- SID 15.38%
- EPS Growth
- ACAD N/A
- SID N/A
- EPS
- ACAD 0.78
- SID N/A
- Revenue
- ACAD $929,236,000.00
- SID $8,019,254,042.00
- Revenue This Year
- ACAD $37.34
- SID N/A
- Revenue Next Year
- ACAD $7.25
- SID $1.48
- P/E Ratio
- ACAD $21.00
- SID N/A
- Revenue Growth
- ACAD 47.06
- SID N/A
- 52 Week Low
- ACAD $14.15
- SID $1.82
- 52 Week High
- ACAD $32.59
- SID $4.03
- Technical
- Relative Strength Index (RSI)
- ACAD 51.17
- SID 41.69
- Support Level
- ACAD $16.02
- SID $1.82
- Resistance Level
- ACAD $16.68
- SID $2.05
- Average True Range (ATR)
- ACAD 0.58
- SID 0.07
- MACD
- ACAD -0.09
- SID -0.00
- Stochastic Oscillator
- ACAD 25.70
- SID 36.96
About ACAD ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
About SID Companhia Siderurgica Nacional S.A.
Companhia Siderurgica Nacional is an integrated steel producer. The company operate throughout the entire steel production chain, from the mining of iron ore to the production and sale of a diversified range of steel products. It operates in five segments namely, Steel, Mining, Logistics, Energy, and Cement. It generates maximum revenue from the steel segment. Geographically, it derives a majority of revenue from Asia.